Zobrazeno 1 - 10
of 14
pro vyhledávání: '"André Baruchel"'
Autor:
Theodore W. Laetsch, Shannon L. Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt, Peter Bader, André Baruchel, Michael Boyer, Barbara De Moerloose, Muna Qayed, Jochen Buechner, Michael A. Pulsipher, Gary Douglas Myers, Heather E. Stefanski, Paul L. Martin, Eneida Nemecek, Christina Peters, Gregory Yanik, Seong Lin Khaw, Kara L. Davis, Joerg Krueger, Adriana Balduzzi, Nicolas Boissel, Ranjan Tiwari, Darragh O'Donovan, Stephan A. Grupp
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Tr
Autor:
Nicolas Boissel, Henrique Bittencourt, Peter Bader, André Baruchel, Hidefumi Hiramatsu, Christina Peters, Adriana Balduzzi, Jochen Buechner, Karen Thudium, Joerg Krueger, Marina White, Lamis K. Eldjerou, Susana Rives, Prasanthi Sanjeevi, Barbara De Moerloose
Publikováno v:
Journal of Clinical Oncology. 38:10518-10518
10518 Background: B2001X (NCT03123939) is a multicenter global study of tisa to provide access to patients (pts) with r/r ALL including prior anti-CD19 therapy after enrollment ended in the pivotal ELIANA (NCT02435849) study. We report clinical outco
Autor:
Claudia Rossig, Susana Rives, Markus Schmugge Liner, Jan Starý, Karsten Nysom, Daniel B. Lipka, Irith Baumann, Jennifer Poon, Mathew Simcock, Meera Patturajan, Concetta Micalizzi, Franco Locatelli, Thomas Klingebiel, Christian Flotho, André Baruchel, Charlotte M. Niemeyer, Marry M. van den Heuvel-Eibrink, Marco Zecca, Gérard Michel, Bouchra Benettaib
Publikováno v:
Journal of Clinical Oncology. 37:10031-10031
10031 Background: Hematopoietic stem cell transplantation (HSCT) is the only curative therapy for JMML patients (pts). Novel therapies controlling the disorder prior to HSCT are urgently needed. A phase 2, multicenter, open-label study was conducted
Autor:
Xavier Thomas, Christian Recher, Hervé Dombret, Agnès Guerci, Norbert Vey, Bruno Cassinat, André Baruchel, Nadia Idres, Thierry Leblanc, Pierre Fenaux, Christine Chomienne, Miguel A. Sanz, Guy Leverger, Cecile Bally, Lionel Ades, Yves Bertrand, Alain Robert, Jehane Fadlallah, Emmanuel Raffoux
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2012, 30 (14), pp.1641-6. ⟨10.1200/JCO.2011.38.4560⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2012, 30 (14), pp.1641-6. ⟨10.1200/JCO.2011.38.4560⟩
Purpose Acute promyelocytic leukemia (APL) is rare in children. All-trans-retinoic acid (ATRA) combined with chemotherapy, the reference treatment of APL, is generally considered to produce similar results in children and adults. However, previously
Autor:
Keizo Horibe, Maria Grazia Valsecchi, Ching-Hon Pui, Maurizio Aricò, Valentino Conter, Atsushi Manabe, Stephen P. Hunger, André Baruchel, Vaskar Saha, Lewis B. Silverman, Yves Benoit, Kim Vettenranta, Rob Pieters, Martin Schrappe, Gabriele Escherich, William L. Carroll, Stefania Galimberti
Publikováno v:
Journal of Clinical Oncology, 28(31), 4755-4761. American Society of Clinical Oncology
Purpose In a previous analysis of 326 children with Philadelphia chromosome (Ph) –positive acute lymphoblastic leukemia (ALL) treated between 1986 and 1996, hematopoietic stem-cell transplantation from HLA-matched related donors, but not from unrel
Autor:
Constantine S. Tam, Edmund K. Waller, Karen Thudium Mueller, Gregory A. Yanik, Ulrich Jäger, Peter Borchmann, Jason Hamilton, Michael R. Bishop, André Baruchel, Mariana Cota, Joseph P. McGuirk, Rakesh Awasthi, Michael Boyer, Edward K Waldron, Samantha Jaglowski, Heather E. Stefanski, G.D. Myers, Lida Bubuteishvili-Pacaud, Susana Rives
Publikováno v:
Journal of Clinical Oncology. 36:e15056-e15056
e15056Background: Analyses supporting a safe and efficacious dose for CAR therapies are not well defined and vary across CAR-T programs. These analyses present key considerations to support tisagen...
Autor:
Claudine Schmitt, Marie-Françoise Auclerc, Jean-Michel Cayuela, Gérard Michel, André Baruchel, Guy Leverger, Marianne Debré, Yves Perel, Brigitte Pautard, Thierry Leblanc, Gérard Socié, Raphaël Porcher, Caroline Oudot, Christophe Piguet, Virginie Gandemer, Vincent Levy, Claire Berger, Christiane Vermylen
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. 〈10.1200/JCO.2007.12.2820〉
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, 2008, 26 (9), pp.1496-503. ⟨10.1200/JCO.2007.12.2820⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2008, 26 (9), pp.1496-503. 〈10.1200/JCO.2007.12.2820〉
Purpose To identify prognostic factors and to evaluate the outcome of children with acute lymphoblastic leukemia (ALL) failure after induction therapy. Patients and Methods Between June 1993 and December 1999, 1,395 leukemic children were included in
Autor:
Etienne Vilmer, Consuelo Rayon, Eulogio Conde, J F San Miguel, Dominique Bordessoule, S. de Botton, Nathalie Fegueux, J. de la Serna, André Baruchel, Alain Robert, Jean-Jacques Sotto, Martin F. Fey, Christine Chomienne, Nathalie Philippe, Valérie Coiteux, A Parry, Sylvie Chevret, Miguel A. Sanz, Guy Leverger, Pierre Fenaux, L. Degos
Publikováno v:
Journal of Clinical Oncology. 22:1404-1412
Purpose To determine the results of treatment combining all-trans-retinoic acid (ATRA) and chemotherapy (CT) in childhood acute promyelocytic leukemia (APL). Patients and Methods Children (< 18 years) with newly diagnosed APL were included in the APL
Autor:
Brigitte Nelken, Anne Auvrignon, Yves Perel, Jean-Pierre Vannier, Judith Landman-Parker, Isabelle Thuret, Lionel de Lumley, Schaison G, André Baruchel, Gérard Michel, Brigitte Bader-Meunier, Thierry Leblanc, Gérard Couillaud, Jean-Hugues Dalle, Jean-Pierre Lamagnere, Virginie Gandemer, Claudine Schmitt
Publikováno v:
Journal of Clinical Oncology. 20:2774-2782
PURPOSE: To determine whether the use of maintenance therapy (MT) delivered after intensive induction and consolidation therapy confers any advantage in childhood acute myeloid leukemia (AML). PATIENTS AND METHODS: A total of 268 children with AML we
Autor:
E. Legall, Anne Auvrignon, Christian Berthou, Gérard Michel, Yves Perel, André Baruchel, Guy Leverger, F. Demeocq, F. Bauduer, Pascale Schneider, Brigitte Pautard, Pierre Bordigoni, C. Mathey, Jean-Pierre Lamagnere, Marie-Françoise Auclerc, Schaison G, Judith Landman-Parker, Thierry Leblanc
Publikováno v:
Journal of Clinical Oncology. 18:1517-1524
PURPOSE: To determine whether the use of a recombinant human granulocyte colony-stimulating factor ([G-CSF] lenogastrim) can increase the chemotherapy dose-intensity (CDI) delivered during consolidation chemotherapy of childhood acute lymphoblastic l